162 related articles for article (PubMed ID: 34116213)
1. Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency.
Lanz AL; Riester M; Peters P; Schwerd T; Lurz E; Hajji MS; Rohlfs M; Ley-Zaporozhan J; Walz C; Kotlarz D; Klein C; Albert MH; Hauck F
Clin Immunol; 2021 Aug; 229():108779. PubMed ID: 34116213
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for CTLA4 deficiency.
Slatter MA; Engelhardt KR; Burroughs LM; Arkwright PD; Nademi Z; Skoda-Smith S; Hagin D; Kennedy A; Barge D; Flood T; Abinun M; Wynn RF; Gennery AR; Cant AJ; Sansom D; Hambleton S; Torgerson TR
J Allergy Clin Immunol; 2016 Aug; 138(2):615-619.e1. PubMed ID: 27102614
[No Abstract] [Full Text] [Related]
3. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.
Taghizade N; Babayeva R; Kara A; Karakus IS; Catak MC; Bulutoglu A; Haskologlu ZS; Akay Haci I; Tunakan Dalgic C; Karabiber E; Bilgic Eltan S; Yorgun Altunbas M; Sefer AP; Sezer A; Kokcu Karadag SI; Arik E; Karali Z; Ozhan Kont A; Tuzer C; Karaman S; Mersin SS; Kasap N; Celik E; Kocacik Uygun DF; Aydemir S; Kiykim A; Aydogmus C; Ozek Yucel E; Celmeli F; Karatay E; Bozkurtlar E; Demir S; Metin A; Karaca NE; Kutukculer N; Aksu G; Guner SN; Keles S; Reisli I; Kendir Demirkol Y; Arikoglu T; Gulez N; Genel F; Kilic SS; Aytekin C; Keskin O; Yildiran A; Ozcan D; Altintas DU; Ardeniz FO; Dogu EF; Ikinciogullari KA; Karakoc-Aydiner E; Ozen A; Baris S
J Allergy Clin Immunol; 2023 Dec; 152(6):1634-1645. PubMed ID: 37595759
[TBL] [Abstract][Full Text] [Related]
4. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy.
Ureshino H; Koarada S; Kamachi K; Yoshimura M; Yokoo M; Kubota Y; Ando T; Ichinohe T; Morio T; Kimura S
Int J Hematol; 2020 Jun; 111(6):897-902. PubMed ID: 31993940
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient.
van Leeuwen EM; Cuadrado E; Gerrits AM; Witteveen E; de Bree GJ
J Clin Immunol; 2018 May; 38(4):464-467. PubMed ID: 29796761
[No Abstract] [Full Text] [Related]
6. CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade.
Garcia-Perez JE; Baxter RM; Kong DS; Tobin R; McCarter M; Routes JM; Verbsky J; Jordan MB; Dutmer CM; Hsieh EWY
Front Immunol; 2019; 10():998. PubMed ID: 31156616
[TBL] [Abstract][Full Text] [Related]
7. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.
Kuehn HS; Ouyang W; Lo B; Deenick EK; Niemela JE; Avery DT; Schickel JN; Tran DQ; Stoddard J; Zhang Y; Frucht DM; Dumitriu B; Scheinberg P; Folio LR; Frein CA; Price S; Koh C; Heller T; Seroogy CM; Huttenlocher A; Rao VK; Su HC; Kleiner D; Notarangelo LD; Rampertaap Y; Olivier KN; McElwee J; Hughes J; Pittaluga S; Oliveira JB; Meffre E; Fleisher TA; Holland SM; Lenardo MJ; Tangye SG; Uzel G
Science; 2014 Sep; 345(6204):1623-1627. PubMed ID: 25213377
[TBL] [Abstract][Full Text] [Related]
8. Preponderance of
Siggs OM; Russell A; Singh-Grewal D; Wong M; Chan P; Craig ME; O'Loughlin T; Stormon M; Goodnow CC
Front Immunol; 2019; 10():1544. PubMed ID: 31396201
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
Schubert D; Bode C; Kenefeck R; Hou TZ; Wing JB; Kennedy A; Bulashevska A; Petersen BS; Schäffer AA; Grüning BA; Unger S; Frede N; Baumann U; Witte T; Schmidt RE; Dueckers G; Niehues T; Seneviratne S; Kanariou M; Speckmann C; Ehl S; Rensing-Ehl A; Warnatz K; Rakhmanov M; Thimme R; Hasselblatt P; Emmerich F; Cathomen T; Backofen R; Fisch P; Seidl M; May A; Schmitt-Graeff A; Ikemizu S; Salzer U; Franke A; Sakaguchi S; Walker LSK; Sansom DM; Grimbacher B
Nat Med; 2014 Dec; 20(12):1410-1416. PubMed ID: 25329329
[TBL] [Abstract][Full Text] [Related]
10. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
[TBL] [Abstract][Full Text] [Related]
11. Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept-A Case Report.
Mazzoni M; Dell'Orso G; Grossi A; Ceccherini I; Viola S; Terranova P; Micalizzi C; Guardo D; Massaccesi E; Palmisani E; Calvillo M; Fioredda F; Malattia C; Dufour C; Ravelli A; Miano M
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1168-e1172. PubMed ID: 33625086
[TBL] [Abstract][Full Text] [Related]
12. Two neurologic facets of CTLA4-related haploinsufficiency.
Ayrignac X; Goulabchand R; Jeziorski E; Rullier P; Carra-Dallière C; Lozano C; Portales P; Vincent T; Viallard JF; Menjot de Champfleur N; Rieux-Laucat F; Besnard C; Koenig M; Guissart C; Labauge P; Guilpain P
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32499327
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous
Mahat U; Ambani NM; Rotz SJ; Radhakrishnan K
Pediatr Hematol Oncol; 2021 Oct; 38(7):658-662. PubMed ID: 33900894
[TBL] [Abstract][Full Text] [Related]
14. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency.
Maggiore R; Grossi A; Fioredda F; Palmisani E; Terranova P; Cappelli E; Lanza T; Pierri F; Guardo D; Calvillo M; Micalizzi C; Beccaria A; Coccia MC; Arrigo S; Dufour C; Ceccherini I; Miano M
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e768-e771. PubMed ID: 31876783
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
Hess J; Su L; Nizzi F; Beebe K; Magee K; Salzberg D; Stahlecker J; Miller HK; Adams RH; Ngwube A
Transfusion; 2018 Sep; 58(9):2122-2127. PubMed ID: 30179262
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T Lymphocyte Antigen 4 Haploinsufficiency Presenting As Refractory Celiac-Like Disease: Case Report.
Collen LV; Salgado CA; Bao B; Janssen E; Weir D; Goldsmith J; Leichtner A; Sabery Khavari N; Gernez Y; Snapper SB
Front Immunol; 2022; 13():894648. PubMed ID: 35935971
[TBL] [Abstract][Full Text] [Related]
17. CTLA4-Ig Effectively Controls Clinical Deterioration and Immune Condition in a Murine Model of Foxp3 Deficiency.
Gerbaux M; Roos E; Willemsen M; Staels F; Neumann J; Bücken L; Haughton J; Yshii L; Dooley J; Schlenner S; Humblet-Baron S; Liston A
J Clin Immunol; 2023 Aug; 43(6):1393-1402. PubMed ID: 37156988
[TBL] [Abstract][Full Text] [Related]
18. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
[TBL] [Abstract][Full Text] [Related]
19. CTLA4 haploinsufficiency as a predisposition to classical Hodgkin lymphoma.
Mahat U; Terzioglu MK; Buhtoiarov I
Pediatr Hematol Oncol; 2020 Mar; 37(2):176-183. PubMed ID: 31971458
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review.
Jamee M; Hosseinzadeh S; Sharifinejad N; Zaki-Dizaji M; Matloubi M; Hasani M; Baris S; Alsabbagh M; Lo B; Azizi G
Clin Exp Immunol; 2021 Jul; 205(1):28-43. PubMed ID: 33788257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]